Placebo News and Research

RSS

Broccoli and other cruciferous vegetables may protect against asthma, allergic rhinitis and COPD

Here's another reason to eat your broccoli: UCLA researchers report that a naturally occurring compound found in broccoli and other cruciferous vegetables may help protect against respiratory inflammation that causes conditions like asthma, allergic rhinitis and chronic obstructive pulmonary disease.

2 Mar 2009

Chantix may also help people control drinking

A popular smoking cessation drug dramatically reduced the amount a heavy drinker will consume, a new Yale School of Medicine study has found.

2 Mar 2009

Experimental drug fampridine improves mobility for some MS patients

In MS, the body's immune system attacks myelin, a fatty tissue that wraps and insultates nerve fibers, disrupting the transmission of signals in the central nervous system.

1 Mar 2009

United States files complaint against Forest Labs for allegedly violating the false claims act with Celexa and Lexapro

A Complaint was unsealed today in U.S. District Court in Massachusetts against a New York pharmaceutical company for alleged False Claims Act violations arising from the company's marketing the drugs Celexa and Lexapro for unapproved pediatric use and for paying kickbacks to induce physicians to prescribe the drugs.

25 Feb 2009

Valdoxan granted marketing authorisation for the treatment of major depressive episodes in Europe

The European Commission has granted marketing authorisation for Servier's Valdoxan/Thymanax (agomelatine), the first melatonergic antidepressant for the treatment of adult patients with major depressive episodes.

24 Feb 2009

Vitamins B6 and B12 plus folic acid may reduce risk of age-related macular degeneration in women

Taking a combination of vitamins B6 and B12 and folic acid appears to decrease the risk of age-related macular degeneration in women, according to a report in the February 23 issue of Archives of Internal Medicine , one of the JAMA/Archives journals.

23 Feb 2009

Gene therapy shows potential against HIV

A new UCLA AIDS Institute study has found that gene therapy can be developed as a safe and active technique to combat HIV.

22 Feb 2009

GlaxoSmithKline starts phase III trial of Syncria (albiglutide) type 2 diabetes medication

GlaxoSmithKline has announced initiation and dosing of the first patient of the Phase III clinical trial programme to evaluate the efficacy, safety and tolerability of the investigational GLP-1 (Glucagon-like peptide 1) agonist Syncria (albiglutide) in men and women with type 2 diabetes.

18 Feb 2009

Asthma drugs need to be maintained for continued benefit

Children whose asthma improved while taking steroid drugs for several years did not see those improvements continue after stopping the drugs, new results from a comprehensive childhood asthma study show.

18 Feb 2009

New nationwide Alzheimer's study underway

Researchers at Wake Forest University Baptist Medical Center are preparing to begin a clinical trial aimed at testing an investigational new drug that may help control the progression of Alzheimer's disease.

17 Feb 2009

Experimental antiarrhythmic drug dronedarone reduces death rate in patients with atrial fibrillation

Results from the ATHENA trial, reported in the 12th February issue of the New England Journal of Medicine , suggest that the (as yet unlicensed) antiarrhythmic drug dronedarone can reduce the incidence of cardiovascular-related hospitalisation or death in patients with atrial fibrillation.

16 Feb 2009

Avosentan shows prmoise for diabetic kidney disease

A new drug called avosentan significantly lowers urinary protein excretion-an important marker of kidney disease progression-in patients with diabetic kidney disease, according to an international clinical trial appearing in the March 2009 issue of the Journal of the American Society Nephrology (JASN).

16 Feb 2009

Study on ustekinumab for treatment of psoriatic arthritis published

A group of patients suffering from potentially debilitating psoriatic arthritis showed significant and prolonged improvement after treatment with ustekinumab, according to data from a randomized, double-blind, placebo-controlled study in patients with moderate to severe psoriatic arthritis (PsA).

11 Feb 2009

Placebo News and Research

Broccoli and other cruciferous vegetables may protect against asthma, allergic rhinitis and COPD

Chantix may also help people control drinking

Experimental drug fampridine improves mobility for some MS patients

United States files complaint against Forest Labs for allegedly violating the false claims act with Celexa and Lexapro

Valdoxan granted marketing authorisation for the treatment of major depressive episodes in Europe

Vitamins B6 and B12 plus folic acid may reduce risk of age-related macular degeneration in women

Gene therapy shows potential against HIV

GlaxoSmithKline starts phase III trial of Syncria (albiglutide) type 2 diabetes medication

Asthma drugs need to be maintained for continued benefit

New nationwide Alzheimer's study underway

Experimental antiarrhythmic drug dronedarone reduces death rate in patients with atrial fibrillation

Avosentan shows prmoise for diabetic kidney disease

Study on ustekinumab for treatment of psoriatic arthritis published

ViroPharma reports results of trial for Maribavir in bone marrow transplant patients

Nightly dose of vitamin B12 an effective canker sore therapy

Long-term use of inhaled corticosteroid drugs increases risk of pneumonia for COPD patients

Anti-HIV vaginal gel shows promise

Idenix Pharmaceuticals and GSK sign agreement for novel NNRTI for treatment of HIV

Aspirin cuts stomach cancer risk

Study tests salsalate anti-inflammatory for poorly controlled type 2 diabetes

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News